CLINICAL_TRIALS
trial_result
· 2024-02-09
Clinical Trial Update: International Study for Treatment of Standard Risk Childhood Relapsed ALL 2010 [Phase 3]
Summary
A phase 3 international study evaluating treatment for standard risk childhood relapsed acute lymphoblastic leukemia has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Charite University, Berlin, Germany | Conditions: Acute Lymphoblastic Leukemia (ALL) | Phase 3 | Status: COMPLETED